Xospata
NDC 0469-1425, gilteritinib, tablet, from Astellas Pharma US, Inc..
- Product NDC
- 0469-1425
- Status
- Listed
- Labeler
- Astellas Pharma US, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211349
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0469-1425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GILTERITINIB FUMARATE40 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0469-1425-21 | 00469142521 | 1 BOTTLE in 1 CARTON (0469-1425-21) / 21 TABLET in 1 BOTTLE |
| 0469-1425-90 | 00469142590 | 1 BOTTLE in 1 CARTON (0469-1425-90) / 90 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b5ff59aa-9c0d-49a8-9053-1f179b482383
Use it
Look up 0469-1425 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0469-1425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0469-1425. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.